Utah lawmakers advance bill targeting insulin costs - (The Washington Times via NewsPoints Desk)

  • The cost of insulin could decrease for patients with diabetes after a bill capping copays at $100 a month was advanced by lawmakers in Utah, as reported in The Washington Times.

  • "It curtails the cost to the public," said Kelly Atkinson, director at the Utah Health Insurance Association, but "the pharmaceutical companies control the cost of insulin."

  • The state's House Health and Human Services Committee unanimously approved the bill that would place a cap on the amount certain insurance plans can charge for a month's supply of insulin.

  • The bill will next move to the full House for consideration.

To read more NewsPoints articles, click here.

Reference Articles